Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

Item

http://www.wikidata.org/entity/Q37304301

Q37304301

about

Immunotherapy of systemic sclerosis Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience.Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.Scleroderma lung disease Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design.Emerging targets for the treatment of scleroderma.Spectrum of diffuse parenchymal lung diseases with special reference to idiopathic pulmonary fibrosis and connective tissue disease: An eastern India experience Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.Care of patients with scleroderma in the intensive care setting.Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review.Stem cell autograft and allograft in autoimmune diseases.Recent advances in connective tissue disease related interstitial lung disease.Interstitial lung disease in systemic sclerosis: current and future treatment.Current and future direction in the management of scleroderma.Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis.Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.Anticancer agents against malaria: time to revisit?Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenario.Enteric-coated mycophenolate sodium for progressive systemic sclerosis--a prospective open-label study with CT histography for monitoring of pulmonary fibrosis.Treating CTDs related fibrotic ILDs by immunosuppressants: "facts and faults".Correction: Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies.Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.Quantitative chest CT analysis in patients with systemic sclerosis before and after autologous stem cell transplantation: comparison of results with those of pulmonary function tests and clinical tests.Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients Scleroderma Lung Disease Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis

P2860

Q24634395-61F532BD-C01C-4F84-BC12-DFB749894B81 Q26775753-AC9A04CB-BF74-442D-8488-D4E98F151D22 Q33632260-C232A11D-B1D0-48D7-BB5F-7D453E8DB7FB Q33727800-D2551311-BF13-4442-A7CF-E4174FC29DA3 Q33891119-FEC7DB13-E21D-4CBD-BA0F-9C027C9801B0 Q33919119-A66A17C0-2583-4B5A-B151-E4C8964AD72F Q34027197-62A27464-C74C-41C5-B340-D0B9B41017FC Q34270856-533DC1C3-304D-4777-AF4B-5E1392B4AA2B Q34453106-EFF615A4-5E0C-4983-AA34-E524BEF6D158 Q34727670-A5C9BE62-CCC9-4CB8-AD96-8C02B0851E48 Q36020897-6FBF29CB-7254-4380-9E0F-AC819880B31C Q36046935-9495C2F0-7917-47B9-8574-7FD965BC86F1 Q36664408-477AA436-8934-4CD6-A530-8BC6F132939C Q37764618-CA97087C-FD9E-4CC0-9A7C-353B2ABB3AEE Q38242079-DC740293-4E9B-4134-A804-1FBDF0860243 Q38287103-50371FE8-39C3-43EB-A497-04EC833659C4 Q38678939-DE699510-7C11-4F56-A766-FD50BE8D8040 Q38773637-7D101748-7CC5-466C-8104-B1CD7B5940A5 Q38823948-6BE7A644-29FA-49BF-B90F-ED4A23D68CB3 Q39322066-DFBEFCCD-3A52-4998-AC75-5BEF5B82A72F Q39466706-02E148B7-B7EA-4270-9BBB-9AE0522B77F9 Q40528423-C8BE2A0D-37CD-4F3F-910B-00E63576EAFB Q42488257-0884F979-C7D8-4E1C-9650-0789E42BFA01 Q42963326-38FE8EA8-926B-4018-A80F-6DAEB61F0467 Q45395276-B776778F-95C6-42D9-83D8-A86C05F82DC4 Q45925445-B43B2C09-07EE-4B8C-8E66-1EED90CB8DAE Q46951824-7F86F2D1-3915-496A-965B-A45D59A8DBFF Q49166002-06AE66C0-3A8E-4DA0-8D37-ABE09265A804 Q51503621-15D2F9D1-8E97-4E5C-86C5-EAB0D3D8BF5E Q56893060-D3D08CF0-E047-4438-9AAC-1A0C0DEBAD3A Q56977976-6EC51EA9-DAFB-4EFA-B291-EC027DFABB85 Q58553753-93DCD8FF-B5DC-4D14-9A23-44EC84CD190F

P2860

Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

Item

http://www.wikidata.org/entity/Q37304301

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of cyclophosphamide on ...... nal prospective cohort studies

@en

Effects of cyclophosphamide on ...... al prospective cohort studies.

@nl

type

Item

label

Effects of cyclophosphamide on ...... nal prospective cohort studies

@en

Effects of cyclophosphamide on ...... al prospective cohort studies.

@nl

prefLabel

Effects of cyclophosphamide on ...... nal prospective cohort studies

@en

Effects of cyclophosphamide on ...... al prospective cohort studies.

@nl

P1476

Effects of cyclophosphamide on ...... nal prospective cohort studies

@en

P2093

Carlotta Nannini

http://www.w3.org/2001/XMLSchema#string

Colin P West

http://www.w3.org/2001/XMLSchema#string

Eric L Matteson

http://www.w3.org/2001/XMLSchema#string

Patricia J Erwin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

New therapeutic strategies for systemic sclerosis--a critical analysis of the literature

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

A power primer

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group.

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.

Cyclophosphamide versus placebo in scleroderma lung disease.

A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

Interstitial lung disease in scleroderma.

P2888

ar2534

P304

R124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1186/AR2534

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2008-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23401623

http://www.w3.org/2001/XMLSchema#string

P698

18937831

http://www.w3.org/2001/XMLSchema#string

P921

interstitial lung disease

patient

organophosphorus compound

P932

2592814

http://www.w3.org/2001/XMLSchema#string

Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

about

P2860

P2860

Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P5008

P577

P5875

P698

P921

P932